Invitrogen Shares Take a Hit | GenomeWeb

Shares in Invitrogen tumbled 14.44 percent for the tracking period ended Tuesday, leading all decliners in the BCW Index this week. The firm missed Wall Street and internal targets for its third quarter at its BioReliance business continues to struggle (see article in this week's issue). Bruker also had a tough week, with its shares dropping 7.43 percent on the heels of its agreement to acquire an X-ray microanalysis business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.